HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Administration of sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate conjugated GP100(25-33) peptide-coupled spleen cells effectively mounts antigen-specific immune response against mouse melanoma.

Abstract
It remains a top research priority to develop immunotherapeutic approaches to induce potent antigen-specific immune responses against tumors. However, in spite of some promising results, most strategies are ineffective because they generate low numbers of tumor-reactive cytotoxic T lymphocytes (CTLs). Here we designed a strategy to enhance antigen-specific immune response via administering sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate (sulfo-SMCC)-conjugated melanoma tumor antigen GP10025-33 peptide-coupled syngeneic spleen cells in a mouse model of melanoma. We found that infusion of GP10025-33 peptide-coupled spleen cells significantly attenuated the growth of melanoma in prophylactic and therapeutic immunizations. Consistent with these findings, the adoptive transfer of spleen cells from immunized mice to naïve syngeneic mice was able to transfer anti-tumor effect, suggesting that GP10025-33 peptide-specific immune response was induced. Further studies showed that, CD8+ T cell proliferation and the frequency of interferon (IFN)-γ-producing CD8+ T cells upon ex vivo stimulation by GP10025-33 were significantly increased compared to control groups. Tumor antigen, GP10025-23 specific immune response was also confirmed by ELISpot and GP100-tetramer assays. This approach is simple, easy-handled, and efficiently delivering antigens to lymphoid tissues. Our study offers an opportunity for clinically translating this approach into tumor immunotherapy.
AuthorsXiaoli Chang, Chang-Qing Xia
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) 2015 Dec 4-11 Vol. 468 Issue 1-2 Pg. 46-52 ISSN: 1090-2104 [Electronic] United States
PMID26545782 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Immunoconjugates
  • Maleimides
  • Peptides
  • gp100 Melanoma Antigen
  • sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate
  • Interferon-gamma
Topics
  • Adoptive Transfer (methods)
  • Animals
  • CD8-Positive T-Lymphocytes (immunology)
  • Cell Line, Tumor
  • Immunoconjugates (administration & dosage, chemistry, therapeutic use)
  • Immunotherapy (methods)
  • Interferon-gamma (immunology)
  • Maleimides (administration & dosage, chemistry, therapeutic use)
  • Melanoma (immunology, prevention & control, therapy)
  • Mice
  • Mice, Inbred C57BL
  • Peptides (administration & dosage, chemistry, therapeutic use)
  • Spleen (cytology, immunology)
  • gp100 Melanoma Antigen (administration & dosage, chemistry, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: